Search Results

5 results

  1. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 03

    The effect of socio-economic inequalities: modelling of population health impact of introducing reduced-risk tobacco products into Germany

    RYTSAR R.(1); DJURDJEVIC S.(1); NUSSBAUM A.(2); KAUL A.(3,4); BENNEWITZ E.(3,4)
    (1) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) Philip Morris GmbH, Gräfelfing, Germany; (3) Saarland University, Department of Economics, Saarbrücken, Germany; (4) IPE Institute for Policy Evaluation, Frankfurt, Germany
    Education, income and occupation are the most commonly used descriptors of social inequalities in health. The socio-economic status (SES) of individuals (or groups of individuals) has proven to be important when describing and understanding smoking ...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 49

    The CORESTA in vitro test battery for combustible tobacco products: update from the 2004 Rationale and Strategy Report

    LEE K.M.(1); JORDAN K.G.(2); WIECZOREK R.(3); MOENNIKES O.(4); CLEMENTS J.(5); CROOKS I.(6); HASHIZUME T.(7); MILLER J.(8); WEBER E.(9); YOSHINO K.(7)
    (1) Altria Client Services, Richmond, VA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.; (3) Imperial Brands, Reemtsma Cigarettenfabriken GmbH, Hamburg, Germany; (4) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (5) Covance Laboratories Ltd, Harrogate, U.K.; (6) British American Tobacco (Investments) Ltd, R&D, Southampton, U.K.; (7) Japan Tobacco Inc., Yokohama, Kanagawa, Japan; (8) JT International SA, Geneva, Switzerland; (9) Ökolab, Vienna, Austria
    In 2004, the CORESTA In Vitro Toxicity Task Force issued a rationale and strategy report, commonly known as “the CORESTA in vitro test battery guideline”. The goals of this guideline were to: 1) develop the rationale and strategy for conducting in vitro ...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 32

    Consumers’ responses to communication materials of a novel heat-not-burn tobacco product

    CHREA C.(1); KALLISCHNIGG G.(2); SANDERS E.(3); BEACHER F.(4); MAGNANI P.(4); RAMAZZOTTI A.(4); WEITKUNAT R.(1)
    (1) Philip Morris Products S.A. (part of Philip Morris International group of companies), PMI R&D, Neuchâtel, Switzerland; (2) ARGUS – Statistics and Information Systems in Environment and Public Health GmbH, Berlin, Germany; (3) Edward Sanders Scientific Consulting, Peseux, Switzerland; (4) Philip Morris International Management S.A. (PMI) (part of Philip Morris International group of companies), Lausanne, Switzerland
    Modified risk tobacco products (MRTPs) are defined by the U.S. Food and Drug Administration (FDA) as tobacco products that are sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco ...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, STPOST 26

    How do consumers use the candidate modified risk tobacco product (MRTP) tobacco heating system (THS): analysis of data from six countries

    ROULET S.(1); MAGNANI P.(1); KALLISCHNIGG G.(2); BADOGLIO S.(1); ACKERMANN K.(3); VEIT M.(3); DUGAN A.(4); GAGE C.(4); KANITSCHEIDER C.(5); APECECHEA M.(5); RAMAZZOTTI A.(1)
    (1) Philip Morris International Management S.A. (PMI), Lausanne, Switzerland; (2) ARGUS – Statistics and Information Systems in Environment and Public Health, Berlin, Germany; (3) FehrAdvice & Partners, Zurich, Switzerland; (4) Kantar Health LLC, New York, U.S.A.; (5) Kantar Health GmbH, Munich, Germany
    PMI conducted consumer studies in several countries for a candidate MRTP, the THS. THS is composed of a tobacco heating device which heats specially designed tobacco sticks. The purpose of these studies was to investigate how adult daily smokers actually ...
  5. TSRC, Tob. Sci. Res. Conf., 2012, 66, abstr. 28

    CSEO – The cigarette smoke exposure ontology

    YOUNESI E.(1), COGGINS C.(2); ANSARI S.(3); HOENG J.(3); PEITSCH M.(3); HOFMANN-APITIUS M.(1)
    (1) Fraunhofer Institute for Algorithms and Scientific Computing SCAI, Sankt Augustin, Germany; (2) Carson Watts Consulting, King, NC, USA; (3) Philip Morris International R&D, Neuchâtel, Switzerland
    In the past years, significant progress has been made in the development and use of experimental settings for collection of massive and precise experimental data on tobacco exposure and the diseases induced by it. Despite the growing number of such data, ...